top of page
Recent Posts
See AllCambridge, MA | December 2022 Shekar Shetty, Clear Scientific Inc.’s CEO, gave an update on our first- in-class therapeutic agent CS-1103 to treat methamphetamine overdose at the Behavioral Health Ca
Boston, MA | October 2022 Team Clear was honored to join hundreds of participants to raise funding and complete a 5K walk to support and raise awareness for the non-profit organization Shatterproof. S
Boston, MA | Sept 2022 There is an urgent need for a safe rapidly acting antidote for methamphetamine. Meth is the fastest growing drug of abuse in the U.S., representing over 798,000 annual emergency
bottom of page